Cover
Cover - shares | 3 Months Ended | ||
Sep. 30, 2021 | Jun. 30, 2021 | Nov. 19, 2021 | |
Cover [Abstract] | |||
Document Type | 10-Q | ||
Amendment Flag | false | ||
Document Quarterly Report | true | ||
Document Period End Date | Sep. 30, 2021 | ||
Document Fiscal Period Focus | Q2 | ||
Document Fiscal Year Focus | 2022 | ||
Current Fiscal Year End Date | --03-31 | ||
Entity File Number | 000-56277 | ||
Entity Registrant Name | Dr. FOODS, Inc. | ||
Entity Central Index Key | 0001857910 | ||
Entity Tax Identification Number | 00-0000000 | ||
Entity Incorporation, State or Country Code | NV | ||
Local Phone Number | 81-90-6002-4978 | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | true | ||
Elected Not To Use the Extended Transition Period | false | ||
Entity Shell Company | true | ||
Common Stock issued and outstanding | 2,315,276,582 | 2,315,276,582 | |
Series Z Preferred Stock Issued and Outstanding | 10,000 | 10,000 |
Balance Sheet
Balance Sheet - USD ($) | Sep. 30, 2021 | Mar. 31, 2021 |
Statement of Financial Position [Abstract] | ||
TOTAL ASSETS | ||
CURRENT LIABILITIES | ||
Accrued Expenses | 3,200 | 3,750 |
TOTAL LIABILITIES | 3,200 | 3,750 |
Stockholders’ Equity (Deficit) | ||
Preferred stock ($.0001 par value, 20,000,000 shares authorized; 10,000 and 0 issued and outstanding as of September 30, 2021 and March 31, 2021, respectively) | 1 | |
Common stock ($.0001 par value, 2,400,000,000 shares authorized, 2,315,276,582 and 0 issued and outstanding as of September 30, 2021 and March 31, 2021,respectively) | 231,528 | |
Additional paid-in capital | 788,648 | 2,010 |
Accumulated deficit | (1,023,377) | (5,760) |
Total Stockholders’ Equity (Deficit) | (3,200) | (3,750) |
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY (DEFICIT) |
Balance Sheet (Parenthetical)
Balance Sheet (Parenthetical) - $ / shares | Sep. 30, 2021 | Mar. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Preferred Stock, Par or Stated Value Per Share | $ 0.0001 | |
Preferred Stock, Shares Authorized | 20,000,000 | |
Preferred Stock, Shares Issued | 10,000 | 0 |
Common Stock, Par or Stated Value Per Share | $ 0.0001 | |
Common Stock, Shares Authorized | 2,400,000,000 | |
Common Stock, Shares, Issued | 2,315,276,582 | 0 |
Condensed Consolidated Statemen
Condensed Consolidated Statement of Operations (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended |
Sep. 30, 2021 | Sep. 30, 2021 | |
Operating Expenses | ||
General and Administrative Expenses | $ 14,192 | $ 1,017,617 |
Total Operating Expenses | 14,192 | 1,017,617 |
Net Loss | $ (14,192) | $ (1,017,617) |
Basic and Diluted Net Loss Per Common Share | $ 0 | $ 0 |
Weighted average number of common shares outstanding- Basic and Diluted | 2,315,276,582 | 1,973,678,398 |
Statement of Changes in Stockho
Statement of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($) | Common Stock [Member] | Preferred Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Total |
Balances, September 30, 2021 | |||||
Balances, June 30, 2021 at Feb. 26, 2021 | |||||
Expenses paid on behalf of the Company and contributed to capital | 2,010 | 2,010 | |||
Net loss | (5,760) | (5,760) | |||
Balances, September 30, 2021 | 2,010 | (5,760) | (3,750) | ||
Balances, June 30, 2021 at Mar. 31, 2021 | 2,010 | (5,760) | (3,750) | ||
Expenses paid on behalf of the Company and contributed to capital | 5,250 | 5,250 | |||
Net loss | (1,003,425) | (1,003,425) | |||
Common shares issued after reorganization | 231,528 | (231,528) | |||
Series Z preferred shares issued after reorganization | 1 | 999,999 | 1,000,000 | ||
Balances, June 30, 2021 at Mar. 31, 2021 | 2,010 | (5,760) | (3,750) | ||
Expenses paid on behalf of the Company and contributed to capital | 18,167 | ||||
Net loss | (1,017,617) | ||||
Common shares issued after reorganization | 1,000,000 | ||||
Balances, September 30, 2021 | 231,528 | 1 | 775,731 | (1,009,185) | (1,925) |
Balances, June 30, 2021 at Jun. 30, 2021 | 231,528 | 1 | 775,731 | (1,009,185) | (1,925) |
Expenses paid on behalf of the Company and contributed to capital | 12,917 | 12,917 | |||
Net loss | (14,192) | (14,192) | |||
Balances, September 30, 2021 | $ 231,528 | $ 1 | $ 788,648 | $ (1,023,377) | $ (3,200) |
Condensed Consolidated Statem_2
Condensed Consolidated Statement of Cash Flows (Unaudited) | 6 Months Ended |
Sep. 30, 2021USD ($) | |
CASH FLOWS FROM OPERATING ACTIVITIES | |
Net loss | $ (1,017,617) |
Adjustment to reconcile net loss to net cash used in operating activities: | |
Common stock issued | |
Preferred stock issued | 1,000,000 |
Changes in current assets and liabilities: | |
Accrued expenses | (550) |
Net cash used in operating activities | (18,167) |
CASH FLOWS FROM FINANCING ACTIVITIES | |
Expenses contributed to capital | 18,167 |
Net cash provided by financing activities | 18,167 |
Net change in cash | 0 |
Beginning cash balance | 0 |
Ending cash balance | 0 |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | |
Interest paid | |
Income taxes paid |
Note 1 Organization and Descrip
Note 1 Organization and Description of Business | 3 Months Ended |
Sep. 30, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Note 1 Organization and Description of Business | Note 1 Organization and Description of Business Dr. Foods, Inc. (we, us, our, the "Company" or the "Registrant"), formerly known as Catapult Solutions, Inc., was incorporated in the State of Nevada on February 26, 2021. On February 26, 2021, Jeffrey DeNunzio was appointed Chief Executive Officer, Chief Financial Officer, and Director of Catapult Solutions, Inc. The Company was created for the sole purpose of participating in a Nevada holding company reorganization pursuant to NRS 92A.180, NRS 92A.200, NRS 92A.230 and NRS 92A.250. The constituent corporations in the Reorganization were Ambient Water Corporation (“AWGI” or “Predecessor”), Catapult Solutions, Inc. (“Successor”), and Catapult Merger Sub, Inc. (“Merger Sub”). Our director is, and was, the sole director/officer of each constituent corporation in the anticipated Reorganization. Catapult Solutions, Inc. issued 1,000 common shares of its common stock to Predecessor and Merger Sub issued 1,000 shares of its common stock to Catapult Solutions, Inc. immediately prior to the Reorganization. As such, immediately prior to the merger, Catapult Solutions, Inc. became a wholly owned direct subsidiary of Ambient Water Corporation and Merger Sub became a wholly owned and direct subsidiary of Catapult Solutions, Inc. Pursuant to the above, on April 23, 2021, Ambient Water Corporation filed Articles of Merger with the Nevada Secretary of State. The merger became effective on April 28, 2021, at 4:00 PM EST (“Effective Time”). At the Effective Time, Predecessor was merged with and into Merger Sub (the “Merger), and Predecessor became the surviving corporation. Each share of Predecessor common stock issued and outstanding immediately prior to the Effective Time was converted into one validly issued, fully paid and non-assessable share of Catapult Solutions, Inc.’s common stock. At the time of the merger, 10,000 shares of Series Z Preferred Stock were issued to CRS Consulting, LLC, a Wyoming LLC owned and controlled by Jeffrey DeNunzio, Thomas DeNunzio and Paul Moody, for services rendered to the Company. Series Z Preferred Stock has no conversion rights to any other class, and every vote of Series Z Preferred Stock has voting rights equal to 1,000,000 votes of Common Stock. On July 20, 2021, the Company entered into a Share Purchase Agreement (the “Agreement”) by and among CRS Consulting, LLC, a Wyoming Limited Liability Company (“CRS”), White Knight Co., Ltd., a Japan Company (“WKC”), and Next Meats Holdings, Inc., a Nevada Company (“NXMH”), pursuant to which, on July 23, 2021, (“Closing Date”), CRS sold 10,000 shares of the Company’s Series Z Preferred Stock, representing approximately 81.20% voting control of the Company; 5,000 shares of Series Z Preferred Stock were transferred to WKC and 5,000 shares of Series Z Preferred Stock were transferred to NXMH. WKC and NXMH paid consideration of three hundred seventy-five thousand dollars ($375,000) (the “Purchase Price”). The consummation of the transactions contemplated by the Agreement resulted in a change in control of the Company, with WKC and NXMH, becoming the Company’s largest controlling stockholders. On the Closing Date, July 23, 2021, Mr. Jeffrey DeNunzio resigned as the Company’s Chief Executive Officer, Chief Financial Officer, President, Secretary, Treasurer and Director. On the Closing Date, Mr. Koichi Ishizuka was appointed as the Company’s Chief Executive Officer, Chief Financial Officer, President, Secretary, Treasurer, and Director. On August 24, 2021, the Company changed its name with the Nevada Secretary of State to Dr. Foods, Inc. On or about September 17, 2021, we incorporated Dr. Foods Co., Ltd., a Japan Company, as a wholly owned subsidiary of the Company. We intend to utilize Dr. Foods Co., Ltd. to, amongst other things, act as an importer, reseller, developer, and manufacturer of various food products that we may develop in the future. On October 11, 2021, we, through our wholly owned subsidiary Dr. Foods Co., Ltd., entered into and consummated a “Collaboration Agreement” with Next Meats Co., Ltd., a Japan company that shares common management with the Company, to co-develop new food products and subsequently offer them for sale. Next Meats Co., Ltd. operates in the “alternative meat” industry. It currently offers, and plans to continue to offer, amongst other things, artificial chicken and beef products made from meat substitutes. The Collaboration Agreement is for a period of two years, and may be renewed thereafter under the same terms for additional one year terms unless terminated in writing, with three months’ notice, by either party. The Collaboration Agreement, amongst other things, details the terms and conditions by which Next Meats Co., Ltd. and Dr. Foods Co., Ltd. may co-develop, cooperate and contribute towards the development of new products and technologies. The specific allotment of tasks per project will be determined in writing by each party at the outset of collaborative efforts. Dr. Foods Co., Ltd. will primarily, although not exclusively, contribute to research and development, and Next Meats Co., Ltd. will primarily, although not exclusively, contribute to distribution of new products/technologies. Costs pursuant to the collaborative efforts of the partners, will be the respective responsibility of the party responsible for fulfilling such tasks. Dr. Foods Co., Ltd. intends to conduct research and development of new food products pursuant to the Collaboration Agreement via its three new executive officers, all of whom were appointed on October 11 th On November 2, 2021, FINRA announced, on their daily list, that the market effective date of our name change, and ticker symbol change, will be November 3, 2021. On November 3, 2021, we will begin, and have since begun, trading under the symbol DRFS. The new CUSIP number associated with our common stock, as of the market effective date of November 3, 2021, is 26140D107. The Company’s main office is located at 3F K’s Minamiaoyama 6-6-20 Minamiaoyama, Minato-ku, Tokyo 107-0062, Japan. The Company has elected March 31st as its year end. |
Note 2 Summary of Significant A
Note 2 Summary of Significant Accounting Policies | 3 Months Ended |
Sep. 30, 2021 | |
Accounting Policies [Abstract] | |
Note 2 Summary of Significant Accounting Policies | Note 2 Summary of Significant Accounting Policies Basis of Presentation This summary of significant accounting policies is presented to assist in understanding the Company's financial statements. These accounting policies conform to accounting principles, generally accepted in the United States of America, and have been consistently applied in the preparation of the financial statements. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary to make the financial statements not misleading have been included. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents on September 30, 2021, and March 31, 2021, were $ 0 Income Taxes The Company accounts for income taxes under ASC 740, “ Income Taxes Basic Earnings (Loss) Per Share The Company computes basic and diluted earnings (loss) per share in accordance with ASC Topic 260, Earnings per Share The Company does not have any potentially dilutive instruments as of September 30, 2021, and, thus, anti-dilution issues are not applicable. Fair Value of Financial Instruments The Company’s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization. ASC 820, Fair Value Measurements and Disclosures - Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. - Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. - Level 3 - Inputs that are both significant to the fair value measurement and unobservable. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of September 30, 2021. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include accrued expenses. F-5 Table of Contents Related Parties The Company follows ASC 850, Related Party Disclosures, Share-Based Compensation ASC 718, “ Compensation – Stock Compensation The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “ Equity – Based Payments to Non-Employees.” The Company had no stock-based compensation plans as of September 30, 2021, and March 31, 2021. The Company’s stock-based compensation for the periods ended September 30, 2021, and March 31, 2021, was $ 1,000,000 0 Recently Issued Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 We have no assets and or leases and do not believe we will be impacted in the foreseeable future by the newly adopted accounting standard(s) mentioned above. The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations. |
Note 3 Going Concern
Note 3 Going Concern | 3 Months Ended |
Sep. 30, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Note 3 Going Concern | Note 3 Going Concern The Company’s financial statements are prepared in accordance with generally accepted accounting principles applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company demonstrates adverse conditions that raise substantial doubt about the Company's ability to continue as a going concern for one year following the issuance of these financial statements. These adverse conditions are negative financial trends, specifically operating loss, working capital deficiency, and other adverse key financial ratios. The Company has not established any source of revenue to cover its operating costs. Management plans to fund operating expenses with related party contributions to capital. There is no assurance that management's plan will be successful. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be necessary in the event that the Company cannot continue as a going concern. F-6 Table of Contents |
Note 4 Income Taxes
Note 4 Income Taxes | 3 Months Ended |
Sep. 30, 2021 | |
Income Tax Disclosure [Abstract] | |
Note 4 Income Taxes | Note 4 Income Taxes The Company has not recognized an income tax benefit for its operating losses generated based on uncertainties concerning its ability to generate taxable income in future periods. The tax benefit for the period presented is offset by a valuation allowance established against deferred tax assets arising from the net operating losses, the realization of which could not be considered more likely than not. In future periods, tax benefits and related deferred tax assets will be recognized when management considers realization of such amounts to be more likely than not. As of September 30, 2021, the Company has incurred a net loss of approximately $ 1,017,617 211,929 |
Note 5 Commitments and Continge
Note 5 Commitments and Contingencies | 3 Months Ended |
Sep. 30, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Note 5 Commitments and Contingencies | Note 5 Commitments and Contingencies The Company follows ASC 450-20, Los Contingencies, However, on October 11, 2021, we, through our wholly owned subsidiary Dr. Foods Co., Ltd., entered into and consummated a “Collaboration Agreement” with Next Meats Co., Ltd., a Japan company that shares common management with the Company, to co-develop new food products and subsequently offer them for sale. Next Meats Co., Ltd. operates in the “alternative meat” industry. It currently offers, and plans to continue to offer, amongst other things, artificial chicken and beef products made from meat substitutes. The Collaboration Agreement is for a period of two years, and may be renewed thereafter under the same terms for additional one year terms unless terminated in writing, with three months’ notice, by either party. The Collaboration Agreement, amongst other things, details the terms and conditions by which Next Meats Co., Ltd. and Dr. Foods Co., Ltd. may co-develop, cooperate and contribute towards the development of new products and technologies. The specific allotment of tasks per project will be determined in writing by each party at the outset of collaborative efforts. Dr. Foods Co., Ltd. will primarily, although not exclusively, contribute to research and development, and Next Meats Co., Ltd. will primarily, although not exclusively, contribute to distribution of new products/technologies. Costs pursuant to the collaborative efforts of the partners, will be the respective responsibility of the party responsible for fulfilling such tasks. Dr. Foods Co., Ltd. intends to conduct research and development of new food products pursuant to the Collaboration Agreement via its three new executive officers, all of whom were appointed to Dr. Foods Co., Ltd. on October 11 th |
Note 6 Shareholder Equity
Note 6 Shareholder Equity | 3 Months Ended |
Sep. 30, 2021 | |
Equity [Abstract] | |
Note 6 Shareholder Equity | Note 6 Shareholder Equity Preferred Stock The authorized preferred stock of the Company consists of 20,000,000 0.0001 10,000 0 At the time of the reorganization, April 28, 2021, 10,000 On July 20, 2021, the Company entered into a Share Purchase Agreement (the “Agreement”) by and among CRS, White Knight Co., Ltd., a Japan Company (“WKC”), and Next Meats Holdings, Inc., a Nevada Company (“NXMH”), pursuant to which, CRS sold 10,000 shares of the Company’s Series Z Preferred Stock, representing approximately 81.20% voting control of the Company; 5,000 shares of Series Z Preferred Stock were transferred to WKC and 5,000 shares of Series Z Preferred Stock were transferred to NXMH (see Note 1). Common Stock The authorized common stock of the Company consists of 2,400,000,000 0.0001 2,315,276,582 0 At the time of reorganization, April 28, 2021, former shareholders of Ambient Water Corporation became shareholders of Catapult Solutions, Inc., representing all the common shares outstanding. Additional Paid-In Capital The Company’s sole officer and Director, Koichi Ishizuka, paid expenses on behalf of the company and its wholly owned subsidiary totaling $11,067 during the period ended September 30, 2021. These payments are considered contributions to the company with no expectation of repayment and are posted as additional paid-in capital. The Company’s former sole officer and director, Jeffrey DeNunzio, paid expenses on behalf of the company totaling $ 7,100 The Company’s former sole officer and director, Jeffrey DeNunzio, paid expenses on behalf of the company totaling $ 2,010 The $ 9,110 in total payments are considered contributions to the company with no expectation of repayment and are posted as additional paid-in capital. |
Note 7 Subsequent Events
Note 7 Subsequent Events | 3 Months Ended |
Sep. 30, 2021 | |
Subsequent Events [Abstract] | |
Note 7 Subsequent Events | Note 7 Subsequent Events Management has reviewed financial transactions for the Company subsequent to the fiscal quarter ended September 30, 2021 and has found that there was nothing material to disclose. |
Note 2 Summary of Significant_2
Note 2 Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Sep. 30, 2021 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation This summary of significant accounting policies is presented to assist in understanding the Company's financial statements. These accounting policies conform to accounting principles, generally accepted in the United States of America, and have been consistently applied in the preparation of the financial statements. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary to make the financial statements not misleading have been included. Actual results could differ from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. Cash and cash equivalents on September 30, 2021, and March 31, 2021, were $ 0 |
Income Taxes | Income Taxes The Company accounts for income taxes under ASC 740, “ Income Taxes |
Basic Earnings (Loss) Per Share | Basic Earnings (Loss) Per Share The Company computes basic and diluted earnings (loss) per share in accordance with ASC Topic 260, Earnings per Share The Company does not have any potentially dilutive instruments as of September 30, 2021, and, thus, anti-dilution issues are not applicable. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The Company’s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization. ASC 820, Fair Value Measurements and Disclosures - Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. - Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. - Level 3 - Inputs that are both significant to the fair value measurement and unobservable. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of September 30, 2021. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include accrued expenses. |
Related Parties | Related Parties The Company follows ASC 850, Related Party Disclosures, |
Share-Based Compensation | Share-Based Compensation ASC 718, “ Compensation – Stock Compensation The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, “ Equity – Based Payments to Non-Employees.” The Company had no stock-based compensation plans as of September 30, 2021, and March 31, 2021. The Company’s stock-based compensation for the periods ended September 30, 2021, and March 31, 2021, was $ 1,000,000 0 |
Recently Issued Accounting Pronouncements | Recently Issued Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). ASU 2016-02 We have no assets and or leases and do not believe we will be impacted in the foreseeable future by the newly adopted accounting standard(s) mentioned above. The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new pronouncements that have been issued that might have a material impact on its financial position or results of operations. |
Note 2 Summary of Significant_3
Note 2 Summary of Significant Accounting Policies (Details Narrative) - USD ($) | Sep. 30, 2021 | Mar. 31, 2021 |
Accounting Policies [Abstract] | ||
Cash and Cash Equivalents, at Carrying Value | $ 0 | $ 0 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $ 1,000,000 | $ 0 |
Note 4 Income Taxes (Details Na
Note 4 Income Taxes (Details Narrative) - USD ($) | Sep. 30, 2021 | Jun. 30, 2021 |
Income Tax Disclosure [Abstract] | ||
Net loss as of June 30, 2021 | $ 1,017,617 | |
Deferred Income Tax Assets, Net | $ 211,929 |
Note 6 Shareholder Equity (Deta
Note 6 Shareholder Equity (Details Narrative) - USD ($) | Sep. 30, 2021 | Apr. 28, 2021 | Mar. 31, 2021 |
Equity [Abstract] | |||
[custom:Preferredsharesasof-0] | 20,000,000 | ||
preferred par value as of June 30, 2021 | $ 0.0001 | ||
preferred shares as of March 31, 2021 | 10,000 | 0 | |
preferred shares issued on April 28, 2021 | 10,000 | ||
common shares authorized as of June 30, 2021 | 2,400,000,000 | ||
[custom:Commonparvalueasof-0] | $ 0.0001 | ||
Common shares outstanding as of March 31, 2021 | 2,315,276,582 | 0 | |
Expenses paid by officer as of March 31, 2021 | $ 7,100 | $ 2,010 | |
[custom:Totalpaidbyofficerasof-0] | $ 9,110 |